MGRX

Mangoceuticals, Inc. (MGRX) | Rumor.io

Mangoceuticals

MGRX

Attention (50-day avg)0%

Attention rank (50-day avg)#1,840

Bullish sentiment (50-day avg)84%

Price to earnings ratio-0.17

Market capitalization8.3M

Earnings per share-1

Dividend yield (TTM)—

Revenue (annual)456K

Net income (annual)-20.6M

Social

What share of all stock conversation is about MGRX?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% -0.01	0% +0

Aug 14

Mangoceuticals has announced a merger partner Nuclea Energy has signed a definitive deal to buy Moltex reactor and fuel-recycling assets.
The merger agreement was made on July 30th and gives Mangoceuticals until February 1, 2027, to meet compliance.
Analysts are expecting Mangoceuticals to bounce up strongly from the $0.53 region, potentially reaching $1.50.

Generated by AI

Sentiment

Of the messages about MGRX that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	100% +19.37	82.3% +15.33
Bearish	—	—	0% -19.37	17.7% -15.33

Bullish· Aug 14

$MGRX is forming a double bottom, with a strong move up to $1.45 expected.
The merger is expected to be closed today, which could lead to a strong bounce up from the $0.53 region.
The stock is likely to break through the $0.65 level, triggering FOMO and potentially leading to a strong price increase.

Bearish· Aug 6

The company's price may be hit by profit takers from the .40s, potentially reaching $7.
The stock's recent performance has been broken, with the .56 price point no longer holding.
The company's stock is expected to fall further, potentially reaching $0.45, and may be considered a "dogshit" investment.

Generated by AI

Topics

Of the messages about MGRX that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	100%	42.6%
Technical Analysis	—	—	0%	34.69%
Macro	—	—	0%	9.68%
Analysts	—	—	0%	11.39%
Controversies	—	—	0%	1.42%
Earnings	—	—	0%	0.24%

Announcements· Apr 2

Mangoceuticals, Inc. (MGRX) reported a gross margin of 78% and assets totaling $142.9M, supporting scalability and expansion.
The company's Q4 revenue reached $39.1M, with net income of $661K, marking a transition to profitability and strong execution.
Mangoceuticals, Inc. (MGRX) targets massive scale, with a forecast of $16T-$30T by 2030, and has a $40B ecosystem connecting large markets.

Technical Analysis· Mar 23

$MGRX is trying to form higher lows, with a potential curl back to retest/break pre-market highs.
A head and shoulders bear pattern has formed, with a possible descending wedge, and a break above the VWAP at 0.36 needed for a reversal.
$MGRX has shattered its resistance ceiling with massive volume, with an RSI that screamed breakout, and a strong momentum setup shaping up.

Generated by AI

Community

Of the messages about MGRX, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	87.5%	22.34%
Newcomers	—	—	12.5%	77.66%

Regulars· Aug 14

Nuclea Energy's acquisition of Moltex Energy's advanced nuclear technology assets is a significant development for Mangoceuticals, Inc. ($MGRX), with the deal targeting over 80 patents and 9 pending patents in the field.
Mangoceuticals' merger with Nuclea Energy is expected to be completed, but the company's own SEC filings suggest that it is still in a heavy cash burn R&D mode, with revenues cratering and a significant capital requirement on the horizon.
The acquisition of Moltex Energy's assets by Nuclea Energy is expected to be a major step forward for the company, but it may also lead to massive dilution for $MGRX shareholders, as the company may need to seek additional capital to support its development efforts.

Newcomers· Aug 14

Many newcomers are focused on the price action of $MGRX, with some discussing their personal trading experiences and others making predictions about future price movements.
Some newcomers are concerned about the company's compliance with its agreement with Nuclea Energy, citing the deadline of February 1, 2027, and the potential impact on the stock's value.
Newcomers are also discussing the potential merger between Mangoceuticals and Nuclea Energy, with some speculating about the timing and potential effects on the stock's price.

Generated by AI

News

Mangoceuticals Terminates Planned Business Combination with Nuclea

Detailed price information for Mangoceuticals Inc (MGRX-Q) from The Globe and Mail including charting and trades.

1mo agoThe Globe and Mail

12 Consumer Staples Stocks Moving In Thursday's After-Market Session

1mo agobenzinga.com

Mangoceuticals Inc.’s Merger Partner, Nuclea Energy, Inc., Enters into Definitive Agreement to Acquire Moltex Energy’s Advanced Nuclear Technology Assets

The acquisition of Moltex brings over a decade of advanced nuclear R&D, backed by more than C$96 million in private investment and public funding from Canada and the U.S. Department of Energy. Asset-led transaction to add intellectual property and development materials related principally to the SSR-W advanced reactor and WATSS spent nuclear fuel recycling technologies. DALLAS, Texas, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“Mangoceuticals” or the “Company”) today

1mo agoYahoo! Finance Canada

Why is Mangoceuticals stock surging today?

1mo agoInvesting.com

Mangoceuticals’ Merger Partner, Nuclea Energy Inc., Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure

MOU will assess the technical feasibility of integrating Nuclea’s modular reactor technology into New Mining’s data center operations, with a phased evaluation path toward a cumulative 100 MWe of behind-the-meter capacity Dallas, Texas, Aug. ...

1mo agoBarchart.com

Mangoceuticals (MGRX) Stock Jumps Over 49% After Hours: Here's Why Mangoceuticals Stock Jumps 49% After H

Mangoceuticals Shares surged 49.24% after hours as Nuclea Energy advanced nuclear reactor plans boosted merger-related optimism.

1mo agoBenzinga

Also Discussed

Investors talking about MGRX also mention

#	Name	Attention
1	Splash Beverage Group Inc.SBEV	0%new
2	Processa Pharmaceuticals Inc.PCSA	0%0
3	Flash Sports & Media, Inc.UGRO	0%new
4	Onfolio Holdings, Inc.ONFO	0%-0.05
5	MDxHealth SAMDXH	0%0
6	SciSparc Ltd.SPRC	0%+0
7	EON Resources Inc. Class A Common StockEONR	0%0
8	Dogwood Therapeutics Inc.VIRI	0%0
9	FIAC - Focus Impact Acquisition Corp.	——
10	TruGolf Holdings, Inc. Class A Common StockTRUG	0%+0

Mangoceuticals, Inc.

Healthcare
Health Information Services

Mangoceuticals, Inc. is a healthcare company focused on men’s wellness products and services delivered through a telemedicine platform. The company develops, markets, and sells a range of branded offerings that address erectile dysfunction, hair loss, hormone balance and therapy, and weight loss, alongside related online consultations and pharmacy fulfillment services. Its product portfolio includes Mango, Grow, Mojo, and Slim, which are designed for direct-to-consumer access through digital health channels. Mangoceuticals also provides prescribed medications through licensed pharmacy partners as part of its telehealth model, connecting patients with healthcare professionals for online care. Based in Dallas, Texas, and founded in 2021, Mangoceuticals operates in the healthcare services market with a focus on accessible, digitally enabled wellness solutions.

Website

Location

17130 N. Dallas Parkway

Dallas, TX, 75248

United States

Social

What share of all stock conversation is about MGRX?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% -0.01	0% +0

Aug 14

Mangoceuticals has announced a merger partner Nuclea Energy has signed a definitive deal to buy Moltex reactor and fuel-recycling assets.
The merger agreement was made on July 30th and gives Mangoceuticals until February 1, 2027, to meet compliance.
Analysts are expecting Mangoceuticals to bounce up strongly from the $0.53 region, potentially reaching $1.50.

Generated by AI

Sentiment

Of the messages about MGRX that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	100% +19.37	82.3% +15.33
Bearish	—	—	0% -19.37	17.7% -15.33

Bullish· Aug 14

$MGRX is forming a double bottom, with a strong move up to $1.45 expected.
The merger is expected to be closed today, which could lead to a strong bounce up from the $0.53 region.
The stock is likely to break through the $0.65 level, triggering FOMO and potentially leading to a strong price increase.

Bearish· Aug 6

The company's price may be hit by profit takers from the .40s, potentially reaching $7.
The stock's recent performance has been broken, with the .56 price point no longer holding.
The company's stock is expected to fall further, potentially reaching $0.45, and may be considered a "dogshit" investment.

Generated by AI

Topics

Of the messages about MGRX that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	100%	42.6%
Technical Analysis	—	—	0%	34.69%
Macro	—	—	0%	9.68%
Analysts	—	—	0%	11.39%
Controversies	—	—	0%	1.42%
Earnings	—	—	0%	0.24%

Announcements· Apr 2

Mangoceuticals, Inc. (MGRX) reported a gross margin of 78% and assets totaling $142.9M, supporting scalability and expansion.
The company's Q4 revenue reached $39.1M, with net income of $661K, marking a transition to profitability and strong execution.
Mangoceuticals, Inc. (MGRX) targets massive scale, with a forecast of $16T-$30T by 2030, and has a $40B ecosystem connecting large markets.

Technical Analysis· Mar 23

$MGRX is trying to form higher lows, with a potential curl back to retest/break pre-market highs.
A head and shoulders bear pattern has formed, with a possible descending wedge, and a break above the VWAP at 0.36 needed for a reversal.
$MGRX has shattered its resistance ceiling with massive volume, with an RSI that screamed breakout, and a strong momentum setup shaping up.

Generated by AI

Community

Of the messages about MGRX, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	87.5%	22.34%
Newcomers	—	—	12.5%	77.66%

Regulars· Aug 14

Nuclea Energy's acquisition of Moltex Energy's advanced nuclear technology assets is a significant development for Mangoceuticals, Inc. ($MGRX), with the deal targeting over 80 patents and 9 pending patents in the field.
Mangoceuticals' merger with Nuclea Energy is expected to be completed, but the company's own SEC filings suggest that it is still in a heavy cash burn R&D mode, with revenues cratering and a significant capital requirement on the horizon.
The acquisition of Moltex Energy's assets by Nuclea Energy is expected to be a major step forward for the company, but it may also lead to massive dilution for $MGRX shareholders, as the company may need to seek additional capital to support its development efforts.

Newcomers· Aug 14

Many newcomers are focused on the price action of $MGRX, with some discussing their personal trading experiences and others making predictions about future price movements.
Some newcomers are concerned about the company's compliance with its agreement with Nuclea Energy, citing the deadline of February 1, 2027, and the potential impact on the stock's value.
Newcomers are also discussing the potential merger between Mangoceuticals and Nuclea Energy, with some speculating about the timing and potential effects on the stock's price.

Generated by AI

Mangoceuticals

Social

Aug 14

Bullish· Aug 14

Bearish· Aug 6

Announcements· Apr 2

Technical Analysis· Mar 23

Regulars· Aug 14

Newcomers· Aug 14

Mangoceuticals Terminates Planned Business Combination with Nuclea

12 Consumer Staples Stocks Moving In Thursday's After-Market Session

Mangoceuticals Inc.’s Merger Partner, Nuclea Energy, Inc., Enters into Definitive Agreement to Acquire Moltex Energy’s Advanced Nuclear Technology Assets

Why is Mangoceuticals stock surging today?

Mangoceuticals’ Merger Partner, Nuclea Energy Inc., Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure

Mangoceuticals (MGRX) Stock Jumps Over 49% After Hours: Here's Why Mangoceuticals Stock Jumps 49% After H

Also Discussed

Mangoceuticals, Inc.

Company Information

Location

Mangoceuticals Terminates Planned Business Combination with Nuclea

12 Consumer Staples Stocks Moving In Thursday's After-Market Session

Mangoceuticals Inc.’s Merger Partner, Nuclea Energy, Inc., Enters into Definitive Agreement to Acquire Moltex Energy’s Advanced Nuclear Technology Assets

Why is Mangoceuticals stock surging today?

Mangoceuticals’ Merger Partner, Nuclea Energy Inc., Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure

Mangoceuticals (MGRX) Stock Jumps Over 49% After Hours: Here's Why Mangoceuticals Stock Jumps 49% After H

Also Discussed

Social

Aug 14

Bullish· Aug 14

Bearish· Aug 6

Announcements· Apr 2

Technical Analysis· Mar 23

Regulars· Aug 14

Newcomers· Aug 14